title: Diagnosis and Treatment of Anxiety in the Aging Woman.
abstract: The peri- and postmenopausal periods represent a window of vulnerability for emergence of anxiety symptoms and disorders in the life cycle of adult women. Compared to depression, anxiety symptoms and disorders remain largely unexplored during this phase of a woman's life, despite the significant impact on quality of life if not diagnosed and treated. Here, we review the literature to present our current understanding of the epidemiology, causal factors, diagnosis, and treatment of anxiety in the aging woman.
authors.affiliation: Hospital of the University of Pennsylvania, 3535 Market Street, 2nd Floor, Philadelphia, PA, 19104, USA. andrew.siegel@uphs.upenn.edu.|Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. andrew.siegel@uphs.upenn.edu.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Siegel
authors.affiliation: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.|Penn Center for Women's Behavioral Wellness, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Sarah B
authors.initials: SB
authors.lastname: Mathews
mesh_terms: D000375:Aging / Q000523:psychology*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000523:psychology / Q000628:therapy; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000523:psychology; D011613:Psychotherapy / Q000379:methods*; D011619:Psychotropic Drugs / Q000494:pharmacology*; D011788:Quality of Life
chemical_list: D011619:Psychotropic Drugs
keywords: Anxiety and aging; Diagnosis; Estradiol; HPA axis; Medication; Menopause; Perimenopause; Postmenopause; Psychotherapy; Treatment